#AI in science

AI-designed drugs reach Phase III: a 2026 reality check on AI in drug discovery

The first drug candidate discovered with generative AI has entered a Phase III trial, another AI-designed molecule shrank tumours in early cancer data, and Isomorphic Labs is racing to its first human trial. What AI actually speeds up in drug discovery, and what it can't.